Heart valve disease presenting in adults: investigation and management

to another centre. For a short explanation of why the committee made these recommendations and how they might affect practice, see the rationale and impact section on decisions about interventions. Full details of the evidence and the committee's discussion are in evidence review H: transcatheter intervention, surgery or conservative management in heart valve disease. Aortic valve disease For NHS England and NHS Improvement's position on transcatheter aortic valve implantation for people at low or intermediate surgical risk, see the implementation strategy for transcatheter aortic valve implantation. 1.5.3 Offer surgery, if suitable (by median sternotomy or minimally invasive surgery), as first-line intervention for adults with severe aortic stenosis, aortic regurgitation or mixed aortic valve disease and an indication for surgery who are at low or intermediate surgical risk. TAVI is not cost effective for people at low or intermediate surgical risk at the current list price. 1.5.4 Offer TAVI, if suitable, to adults with non-bicuspid severe aortic stenosis who are at high surgical risk or if surgery is unsuitable. 1.5.5 See the recommendations on using TAVI in the NICE interventional procedures guidance on transcatheter aortic valve implantation for aortic stenosis, including entering the details of all people undergoing TAVI into the
